SUGAVIA-50
MRP: 1,350
Packaging: 10x15
Pack Type: tablet
Composition:
Sitagliptin 50mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Description:
Sitagliptin 50mg is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor used to manage type 2 diabetes mellitus. It works by enhancing the levels of incretin hormones, which help the pancreas release more insulin and reduce glucose production by the liver in response to meals. This mechanism effectively improves both fasting and postprandial (after meals) blood glucose levels. Sitagliptin 50mg is suitable as monotherapy or in combination with other antidiabetic agents such as Metformin, Sulfonylureas, or insulin, depending on the patient's needs and response.
Tags:
- Improves blood sugar control without significant risk of hypoglycemia
- Can be combined with other oral antidiabetics or insulin
- Weight-neutral
- Convenient once-daily dosage
- Suitable for long-term glycemic management
Usage Information
Dosage
Take one 50mg tablet once daily, with or without food Swallow whole with water Follow your doctor’s advice and maintain regular glucose monitoring
Side Effects
Headache Nasopharyngitis (cold-like symptoms) Upper respiratory tract infection Mild gastrointestinal discomfort Rare: pancreatitis, allergic reactions, joint pain
Contraindications
Type 1 diabetes or diabetic ketoacidosis Known allergy to Sitagliptin Moderate to severe renal impairment without dose adjustment Pregnancy or lactation without medical supervision
Availability
Sitagliptin 50mg, Sitagliptin tablet, DPP-4 inhibitor, type 2 diabetes medicine, oral diabetes treatment, blood sugar control